BROADCASTS.com

b"Every week, The American Journal of Managed Care\\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care news included comments to several proposals from CMS; Medicare advocates say voters will be motivated by healthcare cost concerns during the midterm elections; research showed diabetes drug dapagliflozin, an SGLT2 inhibitor, reduces risks of major cardiovascular events.\\n\\nRead more about the stories in this podcast:\\nHospital Groups, Others Raise Concerns Over CMS Payment Proposal: https://www.ajmc.com/newsroom/hospital-groups-others-raise-concerns-over-cms-payment-proposal\\nSenate Votes 98-2 to Ban Pharmacist Gag Clauses: https://www.ajmc.com/newsroom/senate-votes-982-to-ban-pharmacist-gag-clauses\\nWhat We're Reading: Safety-Net Readmissions; Gag Clause Bill to Trump; CREATES Impact on Drug Spend: https://www.ajmc.com/newsroom/what-were-reading-safetynet-readmissions-gag-clause-bill-to-trump-creates-impact-on-drug-spend\\nMedicare Advocates Call for Keeping Program as It Is, Cite Voter Concerns About Costs: https://www.ajmc.com/newsroom/medicare-advocates-call-for-keeping-program-as-it-is-cite-voter-concerns-about-costs\\nDiabetes Drug Farxiga Cuts Heart Risks in Topline Results: https://www.ajmc.com/newsroom/diabetes-drug-farxiga-cuts-heart-risks-in-topline-results\\nCVD-REAL Results in More Diverse Countries Link SGLT2s to Lower Risk of Death, Heart Attack, Stroke: https://www.ajmc.com/conferences/acc-2018/cvdreal-results-in-more-diverse-countries-link-sglt2s-to-lower-risk-of-death-heart-attack-stroke\\nPatient-Centered Oncology Care\\xae:\\xa0https://www.ajmc.com/pcoc2018"